STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 59 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $27,000 | -30.8% | 13,203 | -0.1% | 0.00% | – |
Q2 2021 | $39,000 | -97.5% | 13,218 | -97.7% | 0.00% | – |
Q1 2021 | $1,566,000 | +229.7% | 567,134 | +190.6% | 0.00% | – |
Q4 2020 | $475,000 | +58.3% | 195,178 | +36.9% | 0.00% | – |
Q3 2020 | $300,000 | -33.5% | 142,568 | +19.7% | 0.00% | – |
Q2 2020 | $451,000 | +126.6% | 119,099 | +13.4% | 0.00% | – |
Q1 2020 | $199,000 | +3.6% | 105,060 | +15.3% | 0.00% | – |
Q4 2019 | $192,000 | -5.9% | 91,080 | +6.4% | 0.00% | – |
Q3 2019 | $204,000 | +21.4% | 85,563 | +60.4% | 0.00% | – |
Q2 2019 | $168,000 | -58.1% | 53,352 | -33.9% | 0.00% | – |
Q1 2019 | $401,000 | +33.7% | 80,682 | +20.1% | 0.00% | – |
Q4 2018 | $300,000 | +44.9% | 67,169 | +56.8% | 0.00% | – |
Q3 2018 | $207,000 | -18.2% | 42,851 | +1.5% | 0.00% | – |
Q2 2018 | $253,000 | -76.8% | 42,221 | -65.8% | 0.00% | – |
Q1 2018 | $1,091,000 | +236.7% | 123,348 | +176.3% | 0.00% | – |
Q4 2017 | $324,000 | +1250.0% | 44,640 | +1130.4% | 0.00% | – |
Q3 2017 | $24,000 | – | 3,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
&PARTNERS | 15,000 | $28,000 | 0.04% |
Diversified Trust Co | 198,534 | $375,000 | 0.02% |